In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ars Arthro: Taking Tissue Engineering one Step at a Time

Executive Summary

Tissue engineering is one of the most promising technology opportunities in orthopedics. But for the companies that have pursued it, the biological process has become something of a waiting game.

You may also be interested in...



Mining Orthopedics' Niches

Opportunities in meniscus replacement and cartilage repair have long been under-realized in orthopedics--victims of both strong markets for core products, most notably total knee replacements, and the challenges of developing devices that work well. Now two start-ups, sister companies launched by UK-based serial entrepreneurs Oakes, Lyman, believe they've found the technology to tap these opportunities.

Mining Orthopedics' Niches

Opportunities in meniscus replacement and cartilage repair have long been under-realized in orthopedics--victims of both strong markets for core products, most notably total knee replacements, and the challenges of developing devices that work well. Now two start-ups, sister companies launched by UK-based serial entrepreneurs Oakes, Lyman, believe they've found the technology to tap these opportunities.

Joint Resurfacing: Boom or Bust?

One of the hottest topics at the 2007 AAOS was the the trend toward resurfacing rather than completely replacing joints damaged by arthritis and other causes. There are a variety of metallic, synthetic and biologic methods used in hip, knee, shoulder and extremity joint resurfacing, many designed for younger patients who wish to remain active and avoid total joint replacement.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1123738

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel